The possibilities are that NRP1 mediates tumour cell functions either in a VEGF-dependent manner, but independent of VEGFR-2 signalling, or via interaction with other cell-surface receptors and ligands, to transduce signalling and biological functions. Here, CD177 is linked to neoplasm.